Personalized patch for newborn heart surgery
Part of Genetic & congenital, Heart & circulation clinical trials.
This study tests a custom-made patch for repairing the main artery (aorta) during a Norwood procedure in newborns. The patch is designed from each baby's own CT scan to fit better, which may improve surgery outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be 0 to 2 months old
- Your baby needs a Norwood procedure (a heart surgery for severe heart defects) that includes rebuilding the aorta
- You must give your consent for your baby to join
- Your baby cannot have an allergy to CT contrast or kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on improving care for babies born with certain complex heart conditions where only one pumping chamber works. It is meant for babies (including unborn babies) who are planned to have the Norwood procedure, which is a common early surgery.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This trial studies whether a newer “tissue-engineered” blood vessel graft is safe and works well in children who need a specific heart surgery connection outside the heart. It may help by offering a new type of graft, but your team will screen for size and medical factors first.
This trial tests a patch made from lab-grown heart cells that is placed on the heart during bypass surgery. It aims to improve heart function in people with very advanced heart failure who are already having bypass surgery.
This study records newborn heart measurements (using medical imaging) to compare babies with certain congenital heart defects to healthy-term babies. The goal is to see how well one test matches another, which may help doctors better understand heart conditions in newborns.
This trial tests a gel that is injected directly into the heart muscle during the Stage II Glenn operation for children with Hypoplastic Left Heart Syndrome. The goal is to see if the gel is safe and can help the heart function better after surgery.
Hear when a new Hypoplastic Left Heart Syndrome (HLHS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.